Skip to content

A Team-Based Care for Hypertension Management (TBC-HTA)

A Team-Based Care for Hypertension Management (TBC-HTA): A Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02511093
Acronym
TBC-HTA
Enrollment
110
Registered
2015-07-29
Start date
2014-09-30
Completion date
2018-12-31
Last updated
2015-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Team-based care, Collaboration, Healthcare professionals, Healthcare services

Brief summary

The purpose of this study is to determine whether a team-based care (TBC) intervention, combining physician, nurse and pharmacist care improves BP control compared to usual care at 6 months among outpatients with uncontrolled hypertension.

Interventions

BEHAVIORALTBC intervention

A structured collaborative intervention delivered by trained nurses of ambulatory clinics and by community pharmacists working in collaboration with physicians during 6-month of follow-up includes: * BP measurements; * an educational and counselling intervention on patient adherence; * an educational and counselling intervention on lifestyle (physical activity and diet) Physicians adjust antihypertensive medications based on nurse and pharmacist feedback.

Sponsors

University of Applied Sciences of Western Switzerland
CollaboratorOTHER
Université du Québec à Trois-Rivières
CollaboratorOTHER
McGill University
CollaboratorOTHER
Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* treated patients with uncontrolled hypertension (defined as daytime systolic/diastolic ambulatory blood pressure monitoring (ABPM) ≥135/85mmHg) taking one or two antihypertensive medications; * speak and understand French; * agree to use the same pharmacy's services for the whole duration of the study.

Exclusion criteria

* unable to understand the study aim; * pregnancy and lactating; * livimg in a nursing home; * hospitalization during the recruitment period; * participation in another study; * daytime ABPM\>180/110 mmHg.

Design outcomes

Primary

MeasureTime frameDescription
Difference in daytime ABPM at 6-month between TBC and usual care patients6-monthDifference in daytime ABPM at 6-month between TBC and usual care patients
Difference in the proportion of patients with controlled blood pressure (daytime ABPM <135/85 mmHg) at 6-month between TBC and usual care patients6-monthDifference in the proportion of patients with controlled blood pressure (daytime ABPM \<135/85 mmHg) at 6-month between TBC and usual care patients

Secondary

MeasureTime frameDescription
Patients and healthcare professionals' acceptance and satisfaction with the TBC-intervention6-monthPatients and healthcare professionals' acceptance and satisfaction with the TBC-intervention
Difference in the proportion of TBC and usual care patients with controlled blood pressure (daytime ABPM <135/85 mmHg) at 12-month (6 months after intervention stopped)12-monthDifference in the proportion of TBC and usual care patients with controlled blood pressure (daytime ABPM \<135/85 mmHg) at 12-month (6 months after intervention stopped)

Countries

Switzerland

Contacts

Primary ContactValerie Santschi, PhD
v.santschi@ecolelasource.ch0041 21 641 38 24
Backup ContactMichel Burnier, MD
michel.burnier@chuv.ch0041 21 314 11 29

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026